Abstract
Abstract Qualification of analytical instruments has been a complex undertaking, not because the process of qualifying instruments is complex, but because several opinions abound on how to perform a successful qualification. Recently, the United States Pharmacopeia issued General Chapter <1058> to provide guidance for Analytical Instrument Qualification (AIQ). The draft chapter has been published in Pharmacopeial Forum (latest in PF 32:6) and has gone through multiple cycles of public comments. The chapter is scheduled to become official in 2008 (USP 31). The purpose of this chapter is to provide general guidance for the qualification of analytical instrument establishing a common terminology and defining roles and responsibilities of those associated with an instrument’s qualification.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Pappa, H.N., Huynh-Ba, K. (2010). Setting Tolerances for Instrument Qualification USP Chapter <1058>. In: Huynh-Ba, K. (eds) Pharmaceutical Stability Testing to Support Global Markets. Biotechnology: Pharmaceutical Aspects, vol XII. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0889-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0889-6_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0888-9
Online ISBN: 978-1-4419-0889-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)
